| IMD63 | H02525 | Disorders of innate immunity |
| SCID | H00091 | T-B+Severe combined immunodeficiency |
| IMD6 | H00093 | Combined immunodeficiency |
| HTLV-1 | H00009 | Adult T-cell leukemia |
| EBV | H00008 | Burkitt lymphoma |
| H00007 | Hodgkin lymphoma |
| HIES4 | H01968 | Hyper-IgE syndrome |
| HIES5 | H01968 | Hyper-IgE syndrome |
| AIIDE | H02537 | Autoinflammation, immune dysregulation, and eosinophilia |
| HIES1 | H01968 | Hyper-IgE syndrome |
| ADMIO1 | H02540 | Infantile-onset multisystem autoimmune disease |
| KSHV | H00041 | Kaposi sarcoma |
| HBV | H00048 | Hepatocellular carcinoma |
| IBD28 | H01227 | Inflammatory bowel disease (IBD) |
| IBD25 | H01227 | Inflammatory bowel disease (IBD) |
| HCMV | H00368 | Cytomegalovirus infection |
| IMD29 | H00089 | IFN-gamma/IL-12 axis |
| IMD30 | H00089 | IFN-gamma/IL-12 axis |
| IBD17 | H01227 | Inflammatory bowel disease (IBD) |
| THCYT1 | H01612 | Essential thrombocythemia |
| ECYT5 | H00236 | Congenital polycythemia |
| IGHD1 | H02035 | Isolated growth hormone deficiency |
| THCYT2 | H01612 | Essential thrombocythemia |
| MF | H01605 | Myelofibrosis |
| ECYT1 | H00236 | Congenital polycythemia |
| Laron syndrome | H02037 | Laron syndrome |
| THCYT3 | H01612 | Essential thrombocythemia |
| GHISID | H00931 | Growth hormone insensitivity with immunodeficiency |
| IMD45 | H02525 | Disorders of innate immunity |
| IMD44 | H02525 | Disorders of innate immunity |
| PTORCH3 | H00840 | Pseudo-TORCH syndrome |
| IMD65 | H02525 | Disorders of innate immunity |
| PTORCH2 | H00840 | Pseudo-TORCH syndrome |
| IMD27 | H00089 | IFN-gamma/IL-12 axis |
| IMD28 | H00089 | IFN-gamma/IL-12 axis |
| IMD31 | H00089 | IFN-gamma/IL-12 axis |
| CANDF7 | H01109 | Chronic mucocutaneous candidiasis |
Network variation - JAK-STAT signaling
